The Full Wiki

More info on PIAS4

PIAS4: Wikis

Advertisements

Note: Many of our articles have direct quotes from sources you can cite, within the Wikipedia article! This article doesn't yet, but we're working on it! See more info or our list of citable articles.

Encyclopedia

From Wikipedia, the free encyclopedia

edit
Protein inhibitor of activated STAT, 4
Identifiers
Symbols PIAS4; FLJ12419; MGC35296; PIASY; Piasg; ZMIZ6
External IDs OMIM605989 MGI2136940 HomoloGene41071 GeneCards: PIAS4 Gene
RNA expression pattern
PBB GE PIAS4 212881 at tn.png
PBB GE PIAS4 212879 x at tn.png
More reference expression data
Orthologs
Species Human Mouse
Entrez 51588 59004
Ensembl ENSG00000105229 ENSMUSG00000004934
UniProt Q8N2W9 Q3UGQ2
RefSeq (mRNA) NM_015897 NM_021501
RefSeq (protein) NP_056981 NP_067476
Location (UCSC) Chr 19:
3.96 - 3.99 Mb
Chr 10:
80.56 - 80.57 Mb
PubMed search [1] [2]

E3 SUMO-protein ligase PIAS4 is an enzyme that in humans is encoded by the PIAS4 gene.[1][2]

Interactions

PIAS4 has been shown to interact with Mothers against decapentaplegic homolog 6,[3] Mothers against decapentaplegic homolog 7[3] and Lymphoid enhancer-binding factor 1.[4]

References

  1. ^ Liu B, Liao J, Rao X, Kushner SA, Chung CD, Chang DD, Shuai K (Sep 1998). "Inhibition of Stat1-mediated gene activation by PIAS1". Proc Natl Acad Sci U S A 95 (18): 10626–31. PMID 9724754.  
  2. ^ "Entrez Gene: PIAS4 Protein inhibitor of activated STAT, 4". http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=51588.  
  3. ^ a b Imoto, Seiyu; Sugiyama Kenji, Muromoto Ryuta, Sato Noriko, Yamamoto Tetsuya, Matsuda Tadashi (Sep. 2003). "Regulation of transforming growth factor-beta signaling by protein inhibitor of activated STAT, PIASy through Smad3". J. Biol. Chem. (United States) 278 (36): 34253–8. doi:10.1074/jbc.M304961200. ISSN 0021-9258. PMID 12815042.  
  4. ^ Sachdev, S; Bruhn L, Sieber H, Pichler A, Melchior F, Grosschedl R (Dec. 2001). "PIASy, a nuclear matrix-associated SUMO E3 ligase, represses LEF1 activity by sequestration into nuclear bodies". Genes Dev. (United States) 15 (23): 3088–103. ISSN 0890-9369. PMID 11731472.  

Further reading

  • Maruyama K, Sugano S (1994). "Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides.". Gene 138 (1-2): 171–4. doi:10.1016/0378-1119(94)90802-8. PMID 8125298.  
  • Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K, et al. (1997). "Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library.". Gene 200 (1-2): 149–56. doi:10.1016/S0378-1119(97)00411-3. PMID 9373149.  
  • Liu B, Gross M, ten Hoeve J, Shuai K (2001). "A transcriptional corepressor of Stat1 with an essential LXXLL signature motif.". Proc. Natl. Acad. Sci. U.S.A. 98 (6): 3203–7. doi:10.1073/pnas.051489598. PMID 11248056.  
  • Nelson V, Davis GE, Maxwell SA (2001). "A putative protein inhibitor of activated STAT (PIASy) interacts with p53 and inhibits p53-mediated transactivation but not apoptosis.". Apoptosis 6 (3): 221–34. doi:10.1023/A:1011392811628. PMID 11388671.  
  • Gross M, Liu B, Tan J, et al. (2001). "Distinct effects of PIAS proteins on androgen-mediated gene activation in prostate cancer cells.". Oncogene 20 (29): 3880–7. doi:10.1038/sj.onc.1204489. PMID 11439351.  
  • Sachdev S, Bruhn L, Sieber H, et al. (2001). "PIASy, a nuclear matrix-associated SUMO E3 ligase, represses LEF1 activity by sequestration into nuclear bodies.". Genes Dev. 15 (23): 3088–103. doi:10.1101/gad.944801. PMID 11731474.  
  • Ohmine K, Ota J, Ueda M, et al. (2002). "Characterization of stage progression in chronic myeloid leukemia by DNA microarray with purified hematopoietic stem cells.". Oncogene 20 (57): 8249–57. doi:10.1038/sj.onc.1205029. PMID 11781839.  
  • Tan JA, Hall SH, Hamil KG, et al. (2002). "Protein inhibitors of activated STAT resemble scaffold attachment factors and function as interacting nuclear receptor coregulators.". J. Biol. Chem. 277 (19): 16993–7001. doi:10.1074/jbc.M109217200. PMID 11877418.  
  • Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMID 12477932.  
  • Subramanian L, Benson MD, Iñiguez-Lluhí JA (2003). "A synergy control motif within the attenuator domain of CCAAT/enhancer-binding protein alpha inhibits transcriptional synergy through its PIASy-enhanced modification by SUMO-1 or SUMO-3.". J. Biol. Chem. 278 (11): 9134–41. doi:10.1074/jbc.M210440200. PMID 12511558.  
  • Dahle Ø, Andersen TØ, Nordgård O, et al. (2003). "Transactivation properties of c-Myb are critically dependent on two SUMO-1 acceptor sites that are conjugated in a PIASy enhanced manner.". Eur. J. Biochem. 270 (6): 1338–48. doi:10.1046/j.1432-1033.2003.03504.x. PMID 12631292.  
  • Yamamoto H, Ihara M, Matsuura Y, Kikuchi A (2003). "Sumoylation is involved in beta-catenin-dependent activation of Tcf-4.". Embo J. 22 (9): 2047–59. doi:10.1093/emboj/cdg204. PMID 12727872.  
  • Lee PS, Chang C, Liu D, Derynck R (2003). "Sumoylation of Smad4, the common Smad mediator of transforming growth factor-beta family signaling.". J. Biol. Chem. 278 (30): 27853–63. doi:10.1074/jbc.M301755200. PMID 12740389.  
  • Chun TH, Itoh H, Subramanian L, et al. (2003). "Modification of GATA-2 transcriptional activity in endothelial cells by the SUMO E3 ligase PIASy.". Circ. Res. 92 (11): 1201–8. doi:10.1161/01.RES.0000076893.70898.36. PMID 12750312.  
  • Imoto S, Sugiyama K, Muromoto R, et al. (2003). "Regulation of transforming growth factor-beta signaling by protein inhibitor of activated STAT, PIASy through Smad3.". J. Biol. Chem. 278 (36): 34253–8. doi:10.1074/jbc.M304961200. PMID 12815042.  
  • Galleguillos D, Vecchiola A, Fuentealba JA, et al. (2004). "PIASgamma represses the transcriptional activation induced by the nuclear receptor Nurr1.". J. Biol. Chem. 279 (3): 2005–11. doi:10.1074/jbc.M308113200. PMID 14559918.  
  • Gross M, Yang R, Top I, et al. (2004). "PIASy-mediated repression of the androgen receptor is independent of sumoylation.". Oncogene 23 (17): 3059–66. doi:10.1038/sj.onc.1207443. PMID 14981544.  
  • Zoumpoulidou G, Jones MC, Fernandez de Mattos S, et al. (2005). "Convergence of interferon-gamma and progesterone signaling pathways in human endometrium: role of PIASy (protein inhibitor of activated signal transducer and activator of transcription-y).". Mol. Endocrinol. 18 (8): 1988–99. doi:10.1210/me.2003-0467. PMID 15155784.  
  • Imoto S, Sugiyama K, Yamamoto T, Matsuda T (2004). "The RING domain of PIASy is involved in the suppression of bone morphogenetic protein-signaling pathway.". Biochem. Biophys. Res. Commun. 319 (1): 275–82. doi:10.1016/j.bbrc.2004.04.161. PMID 15158472.  
Advertisements

Advertisements






Got something to say? Make a comment.
Your name
Your email address
Message